Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jared D Huling

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
The Lancet. Infectious Diseases|June 11, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trialCarolyn T Bramante, John B Buse, David M Liebovitz, et al.
The New England Journal of Medicine|September 7, 2022
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19Carolyn T Bramante, Jared D Huling, Christopher J Tignanelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2024
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical TrialCarolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
The Lancet. Infectious Diseases|June 11, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trialCarolyn T Bramante, John B Buse, David M Liebovitz, et al.
The New England Journal of Medicine|September 7, 2022
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19Carolyn T Bramante, Jared D Huling, Christopher J Tignanelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2024
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical TrialCarolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Pageof 6